MoneyWorks4Me

Divi’s Laboratories reports 27% rise in Q1 consolidated net profit

07 Aug 2025 Evaluate

Divi’s Laboratories has reported result for first quarter ended June 30, 2025 (Q1FY26).

The company has reported 29.53% rise in its net profit at Rs 557.00 crore for the quarter ended June 30, 2025 as compared to Rs 430.00 crore for the same quarter in the previous year. The total income of the company increased by 15.59% at Rs 2476.00 crore for Q1FY26 as compared to Rs 2142.00 crore for the corresponding quarter previous year.

On consolidated basis, the company has reported 26.74% rise in its net profit at Rs 545.00 crore for Q1FY26 as compared to Rs 430.00 crore for the same quarter in the previous year. The total income of the company increased by 15.11% at Rs 2529.00 crore for Q1FY26 as compared to Rs 2197.00 crore for the corresponding quarter previous year.

Peers
Company Name CMP
Sun Pharma. Inds. 1868.00
Dr. Reddys Labs. 1202.00
Cipla 1385.00
Lupin 2120.00
Zydus Lifesciences 1161.50
View more..